Prot #ML30172: Scleroderma Lung Study III (SLS III): Combining the anti‐fibrotic effects of pirfenidone (PFD) with mycophenolate (MMF) for treating scleroderma-related interstitial lung disease

Project: Research project

Project Details

StatusActive
Effective start/end date1/24/18 → 1/24/24

Funding

  • University of California at Los Angeles (Prot #ML30172)
  • Genentech, Inc. (Prot #ML30172)